1. Academic Validation
  2. Inherited IL-18BP deficiency in human fulminant viral hepatitis

Inherited IL-18BP deficiency in human fulminant viral hepatitis

  • J Exp Med. 2019 Aug 5;216(8):1777-1790. doi: 10.1084/jem.20190669.
Serkan Belkaya 1 Eleftherios Michailidis # 2 Cecilia B Korol # 3 4 Mohammad Kabbani 2 Aurélie Cobat 3 4 Paul Bastard 1 Yoon Seung Lee 1 Nicholas Hernandez 1 Scott Drutman 1 Ype P de Jong 2 5 Eric Vivier 6 7 8 Julie Bruneau 4 9 Vivien Béziat 1 3 4 Bertrand Boisson 1 3 4 Lazaro Lorenzo-Diaz 3 4 Soraya Boucherit 3 4 Mylène Sebagh 10 Emmanuel Jacquemin 11 12 Jean-François Emile 13 Laurent Abel 1 3 4 Charles M Rice 2 Emmanuelle Jouanguy # 1 3 4 Jean-Laurent Casanova # 14 3 4 15 16
Affiliations

Affiliations

  • 1 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
  • 2 Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
  • 3 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
  • 4 Paris Descartes University, Imagine Institute, Paris, France.
  • 5 Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY.
  • 6 Aix Marseille Université, INSERM, Centre National de la Recherche Scientifique, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • 7 Service d'Immunologie, Marseille Immunopole, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • 8 Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
  • 9 Department of Pathology, Assistance Publique-Hôpitaux de Paris, Necker Hospital for Sick Children, Paris, France.
  • 10 Department of Pathology, Hepato-biliary Center, Assistance Publique-Hôpitaux de Paris, Paul Brousse Hospital, Villejuif, France.
  • 11 Pediatric Hepatology and Liver Transplantation Unit, National Reference Centre for Rare Pediatric Liver Diseases, Assistance Publique-Hôpitaux de Paris, Bicêtre University Hospital, University of Paris Sud-Saclay, Le Kremlin Bicêtre, France.
  • 12 INSERM U1174, University of Paris Sud-Saclay, Hepatinov, Orsay, France.
  • 13 Department of Pathology, Assistance Publique-Hôpitaux de Paris, Ambroise Paré Hospital, Boulogne-Billancourt, France.
  • 14 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY [email protected].
  • 15 Pediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, Paris, France.
  • 16 Howard Hughes Medical Institute, New York, NY.
  • # Contributed equally.
Abstract

Fulminant viral hepatitis (FVH) is a devastating and unexplained condition that strikes otherwise healthy individuals during primary Infection with common liver-tropic viruses. We report a child who died of FVH upon Infection with hepatitis A virus (HAV) at age 11 yr and who was homozygous for a private 40-nucleotide deletion in IL18BP, which encodes the IL-18 binding protein (IL-18BP). This mutation is loss-of-function, unlike the variants found in a homozygous state in public databases. We show that human IL-18 and IL-18BP are both secreted mostly by hepatocytes and macrophages in the liver. Moreover, in the absence of IL-18BP, excessive NK cell activation by IL-18 results in uncontrolled killing of human hepatocytes in vitro. Inherited human IL-18BP deficiency thus underlies fulminant HAV hepatitis by unleashing IL-18. These findings provide proof-of-principle that FVH can be caused by single-gene inborn errors that selectively disrupt liver-specific immunity. They also show that human IL-18 is toxic to the liver and that IL-18BP is its antidote.

Figures